Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in at-risk patient groups: pregnancy, elderly and obese patients
Abstract Background Venous thromboembolism (VTE) accounts for an estimated 900,000 cases per year in the US alone and constitutes a considerable burden on healthcare systems across the globe. Objective To understand why the burden is so high, qualitative and quantitative research was carried out to...
Main Authors: | Benjamin Brenner, Roopen Arya, Jan Beyer-Westendorf, James Douketis, Russell Hull, Ismail Elalamy, Davide Imberti, Zhenguo Zhai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-12-01
|
Series: | Thrombosis Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12959-019-0214-8 |
Similar Items
-
Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in high-risk patient groups: cancer and critically ill
by: Benjamin Brenner, et al.
Published: (2019-04-01) -
The use of enoxaparin as venous thromboembolism prophylaxis in bariatric surgery: A retrospective cohort study
by: Esraa Altawil, et al.
Published: (2022-10-01) -
Risk Factors, Prophylaxis, and Treatment of Venous Thromboembolism in Congenital Heart Disease Patients
by: Michael Silvey, et al.
Published: (2017-06-01) -
Assessment of anti-factor Xa activity of enoxaparin for venous thromboembolism prophylaxis in morbidly obese surgical patients
by: Nouf Al Otaib, et al.
Published: (2017-01-01) -
Factor Xa inhibitors versus vitamin K antagonist in morbidly obese patients with venous thromboembolism: a systematic review and meta-analysis
by: Dae Yong Park, et al.
Published: (2023-02-01)